Caring Brands Announces Its IP Portfolio Now Includes Five Issued U.S. Patents Covering Two Of Its Main Product Platforms, Hair Enzyme Booster And Photocil

Four of the issued patents cover Hair Enzyme Booster, while the fifth supports Photocil. Together, these patents establish a strong IP moat supporting Caring Brands’ licensing-led commercialization strategy and ongoing strategic partner discussions. Additional U.S. and international patent applications remain in active prosecution across multiple countries.

Key Product Platforms & Market Opportunities

Hair Enzyme Booster ($1.8B+ Market Opportunity): Covered by a four-patent family protecting compositions and methods relating to sulfotransferase enzyme activity and minoxidil metabolism. Up to 50% to 60% of minoxidil users fail to see optimal results due to low baseline scalp enzyme levels. Designed for use alongside topical minoxidil, Hair Enzyme Booster optimizes the enzymatic environment to boost activity, directly addressing an estimated 80+ million hair loss sufferers in the U.S. alone.

Photocil ($20B+ Dermatology Market Opportunity): Covered by an issued U.S. patent protecting methods and compositions involving selective transmission and filtration of specific ultraviolet (UV) light wavelengths. Photocil functions as a topical narrow-band UV filter engineered for targeted skin health applications, addressing global patient populations of over 125 million psoriasis sufferers and 100 million vitiligo sufferers who rely on safe phototherapy solutions.

Commercial Readiness & Multi-Channel Strategy

Caring Brands is actively advancing operational and partner readiness to support expanded product availability. Building upon established international partnerships, including licensing agreements with global leaders like Taisho Pharmaceutical, ongoing commercialization initiatives include:

Coordination of scalable third-party manufacturing and supply logistics.
Alignment of packaging, labeling, and regulatory compliance frameworks.
Preparation of comprehensive diligence materials for prospective licensees and regional distributors.
Execution of a hybrid commercial model anchored by primary B2B licensing partnerships and supplemented by targeted direct-to-consumer (DTC) sales via Amazon and select retail channels.